[go: up one dir, main page]

AU1678900A - A novel liposomal formulation useful in treatment of cancer and other proliferation diseases - Google Patents

A novel liposomal formulation useful in treatment of cancer and other proliferation diseases

Info

Publication number
AU1678900A
AU1678900A AU16789/00A AU1678900A AU1678900A AU 1678900 A AU1678900 A AU 1678900A AU 16789/00 A AU16789/00 A AU 16789/00A AU 1678900 A AU1678900 A AU 1678900A AU 1678900 A AU1678900 A AU 1678900A
Authority
AU
Australia
Prior art keywords
cancer
treatment
liposomal formulation
formulation useful
proliferation diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16789/00A
Inventor
Suresh Kumar Gupta
Shiladitya Sengupta
Thirumurthy Velpandian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
All India Institute of Medical Sciences AIIMS
Original Assignee
All India Institute of Medical Sciences AIIMS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by All India Institute of Medical Sciences AIIMS filed Critical All India Institute of Medical Sciences AIIMS
Publication of AU1678900A publication Critical patent/AU1678900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU16789/00A 1998-08-11 1999-08-10 A novel liposomal formulation useful in treatment of cancer and other proliferation diseases Abandoned AU1678900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2337DE1998 1998-08-11
IN2337/DEL/98 1998-08-11
PCT/IN1999/000037 WO2000009071A2 (en) 1998-08-11 1999-08-10 A novel liposomal formulation useful in treatment of cancer and other proliferation diseases

Publications (1)

Publication Number Publication Date
AU1678900A true AU1678900A (en) 2000-03-06

Family

ID=11092773

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16789/00A Abandoned AU1678900A (en) 1998-08-11 1999-08-10 A novel liposomal formulation useful in treatment of cancer and other proliferation diseases

Country Status (2)

Country Link
AU (1) AU1678900A (en)
WO (1) WO2000009071A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030147944A1 (en) * 1999-12-10 2003-08-07 Mayer Lawrence D Lipid carrier compositions with protected surface reactive functions
EP1261337B1 (en) * 2000-02-28 2008-09-10 The University Of British Columbia Topoisomerase inhibitors for treatment of surgical adhesions
KR101376895B1 (en) * 2004-05-03 2014-03-25 헤르메스 바이오사이언스, 인코포레이티드 Liposomes useful for drug delivery
US8658203B2 (en) 2004-05-03 2014-02-25 Merrimack Pharmaceuticals, Inc. Liposomes useful for drug delivery to the brain
AU2006235538A1 (en) 2005-04-12 2006-10-19 Wisconsin Alumni Research Foundation Micelle composition of polymer and passenger drug
US8236329B2 (en) 2009-09-25 2012-08-07 Wisconsin Alumni Research Foundation Micelle encapsulation of therapeutic agents
RS67289B1 (en) 2015-10-16 2025-11-28 Ipsen Biopharm Ltd Stabilizing camptothecin pharmaceutical compositions
CN111701026B (en) * 2020-06-28 2022-10-21 吴燕 Anti-tumor combined drug nano-carrier and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910014122A (en) * 1990-01-19 1991-08-31 디께다 가즈히꼬 Lyophilized Formulation of Etoposide-2-dimethylamino Compound
US5534499A (en) * 1994-05-19 1996-07-09 The University Of British Columbia Lipophilic drug derivatives for use in liposomes
US5741516A (en) * 1994-06-20 1998-04-21 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
US6214388B1 (en) * 1994-11-09 2001-04-10 The Regents Of The University Of California Immunoliposomes that optimize internalization into target cells

Also Published As

Publication number Publication date
WO2000009071A3 (en) 2000-06-15
WO2000009071A2 (en) 2000-02-24

Similar Documents

Publication Publication Date Title
AU6849396A (en) Method for treatment of cancer and infectious diseases and compositions useful in same
AU3890297A (en) Herbal formulation and therapeutic uses therefor
AUPN698495A0 (en) Improved therapeutic formulation and method
AU1568899A (en) Massage and skin suction apparatus
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU7907300A (en) Novel combination of loteprednol and antihistamines
AU3068699A (en) Skin equivalent and methods of forming and using same
AU1164601A (en) Therapeutic use and formulation
AU6435398A (en) Prevention and treatment of hepatocellular cancer
AUPQ201499A0 (en) Treatment of inflammatory and malignant diseases
AU1678900A (en) A novel liposomal formulation useful in treatment of cancer and other proliferation diseases
AU6968098A (en) Topical treatment of skin diseases and eye afflictions
IL123156A0 (en) Benzenesulphonamide derivatives their preparation and their application in therapy
AU2587195A (en) Growth hormone therapy and related methods and pharmaceutical compositions
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
AU1068499A (en) Injection-moldable composition and article of manufacture comprising same
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU2001276462A1 (en) Use of natural products in cancer treatment
AU2905995A (en) Brefeldin A derivatives and their utility in the treatment of cancer
AU3361595A (en) Formulation and use of carotenoids in treatment of cancer
AU5697996A (en) Peptidyl compounds and their therapeutic use
AU5871898A (en) Microparticles and their use in cancer treatment
AU9358398A (en) Use of p-glycoprotein (pgp) inhibitors in the treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase